| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | 1 | +$8.0K | Bought Aug 18, 26 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Aug 18, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Sep 10, 26 (23d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Mazelsky Jonathan JayDirector | Stock Award(Grant) at price 0.00 per share. | 1.4K | — |
| Jun 29, 2026 | Huffines Robert LutherDirector | Stock Award(Grant) at price 159.79 per share. | 144 | $23.01K |
| Jun 29, 2026 | Huffines Robert LutherDirector | Stock Award(Grant) at price 152.25 per share. | 151 | $22.99K |
| Jun 2, 2026 | Borio LucianaDirector | Sale at price 143.27 per share. | 418 | $59.89K |
| Jun 2, 2026 | Weatherman Elizabeth HDirector | Purchase at price 144.20 per share. | 3.5K | $497.49K |
| Jun 2, 2026 | Stonesifer Timothy CDirector | Purchase at price 143.51 per share. | 2.8K | $400.39K |
| May 19, 2026 | Scannell Timothy J.Director | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| May 19, 2026 | Weatherman Elizabeth HDirector | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| May 19, 2026 | Hopfield JessicaDirector | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| May 19, 2026 | Stonesifer Timothy CDirector | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| May 19, 2026 | Minogue Michael RDirector | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| May 19, 2026 | Huffines Robert LutherDirector | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| May 19, 2026 | Frederick Wayne A.I.Director | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| May 19, 2026 | Borio LucianaDirector | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| Mar 31, 2026 | Panos MichaelOfficer | Stock Award(Grant) at price 0.00 per share. | 2.8K | — |
| Mar 30, 2026 | Huffines Robert LutherDirector | Stock Award(Grant) at price 209.84 per share. | 111 | $23.29K |
| Feb 24, 2026 | Minogue Michael RDirector | Purchase at price 246.23 per share. | 2K | $499.85K |
| Feb 23, 2026 | Benjamin EricChief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 3.8K | — |
| Feb 23, 2026 | Mcevoy AshleyChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 10K | — |
| Feb 23, 2026 | Kapples John W.General Counsel | Stock Award(Grant) at price 0.00 per share. | 1.9K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.0 | -3.6 | -14.9 | -18.0 | -15.8 | 5.0 | 8.6 | -10.1 | -12.2 | 7.2 | −50.8% | ||
| 2025 | 6.6 | -2.2 | -3.5 | -3.9 | 28.8 | -3.3 | -8.2 | 17.9 | -9.2 | 1.4 | 4.5 | -13.1 | +8.9% |
| 2024 | -12.0 | -14.1 | 4.5 | 0.3 | 3.1 | 13.9 | -3.7 | 4.3 | 14.8 | -0.5 | 15.2 | -2.1 | +20.3% |
| 2023 | -2.4 | -3.8 | 15.4 | -0.3 | -13.8 | 5.1 | -4.0 | -30.7 | -16.8 | -16.9 | 42.6 | 14.7 | −26.3% |
| 2022 | -6.8 | 6.7 | 0.6 | -10.3 | -10.7 | 2.1 | 13.7 | 3.1 | -10.2 | 12.8 | 15.7 | -1.7 | +10.6% |
| 2021 | 4.5 | -3.0 | 0.7 | 13.1 | -8.7 | 1.8 | 1.9 | 6.5 | -4.6 | 9.1 | -7.0 | -7.8 | +4.1% |
| 2020 | 13.3 | -2.1 | -12.8 | 20.5 | -5.6 | 3.0 | 4.7 | 7.3 | 8.4 | -6.1 | 16.0 | -0.8 | +49.3% |
| 2019 | 2.4 | 15.7 | 1.3 | -9.3 | 27.3 | 8.7 | 3.0 | 25.4 | 7.0 | -11.9 | 27.8 | -7.8 | +115.8% |
| 2018 | 10.9 | -1.9 | 15.4 | -0.8 | 9.1 | -8.6 | -3.0 | 25.4 | 1.6 | -16.7 | -4.9 | -5.5 | +15.0% |
| 2017 | 10.4 | 4.7 | -1.1 | 0.7 | -3.3 | 22.3 | -1.9 | 15.4 | -5.1 | 6.8 | 22.0 | -3.8 | +83.1% |
| 2016 | -12.2 | -7.7 | 8.2 | 0.4 | -9.8 | 0.7 | 17.0 | 19.6 | -3.3 | -9.3 | -9.3 | 12.0 | −0.3% |
| 2015 | -36.2 | 8.0 | 5.1 | -10.5 | -5.3 | 9.6 | 9.4 | -12.3 | -12.8 | 15.4 | 22.4 | 3.3 | −17.9% |
| 2014 | 15.9 | 10.3 | 0.0 | -20.6 | -2.7 | 8.3 | -10.9 | 2.2 | 2.0 | 17.2 | 7.9 | -1.1 | +24.2% |
| 2013 | 8.7 | -2.2 | 14.6 | -2.4 | 18.3 | 5.2 | 1.5 | 4.5 | 8.7 | 7.8 | -5.2 | 0.2 | +74.8% |
| 2012 | 3.3 | 1.4 | -3.0 | -6.7 | 3.1 | 16.0 | -8.5 | 7.2 | 2.9 | -1.7 | 3.5 | -3.3 | +12.7% |
| 2011 | 9.9 | 4.3 | 16.0 | 4.2 | -1.9 | 5.2 | -11.3 | -11.1 | -12.7 | 6.9 | 13.8 | 1.3 | +21.5% |
| 2010 | -4.6 | 7.9 | 2.7 | -8.5 | 5.5 | 3.3 | -1.7 | -10.6 | 7.0 | 12.8 | -14.9 | 14.2 | +8.5% |
| 2009 | 2.8 | -22.9 | -33.0 | 40.2 | 25.7 | 6.5 | -13.0 | 37.5 | 21.9 | -1.2 | 10.5 | 16.5 | +85.0% |
| 2008 | -15.6 | -13.5 | -15.9 | 27.2 | -11.0 | -3.5 | -11.3 | 2.8 | -2.9 | -59.8 | -12.7 | 57.9 | −67.1% |
| 2007 | -4.2 | -1.3 | 25.7 | 23.4 | 15.1 | 9.7 | -14.5 | +58.4% |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Buy / hold / sell counts